DR Jennifer Devlin
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
31 Scholarly works
4 Projects
HIGHLIGHTS
2026
Journal article
Sensitivity of pancreatic adenocarcinoma cells to blockade of post-initiation CDK-dependent Pol II transcription cycle checkpoints.
DOI: 10.1158/1535-7163.MCT-25-15292026
Journal article
An orally active dual CBP/p300 degrader targets core dependencies of multiple myeloma
DOI: 10.1016/j.celrep.2026.1174642026
Journal article
Abstract LB476: Combined inhibition of transcription initiation and histone deacetylation triggers blood cancer cell death
DOI: 10.1158/1538-7445.am2026-lb4762025
Journal article
A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation
DOI: 10.1016/j.molcel.2025.08.0012024
Research grants (international)
Multi-Point Targeting of Gene Expression Regulatory Cycles as an Anticancer Therapeutic Strategy
2023
Research grants (other domestic)
Targeting Oncogenic Pol-Ii Transcription Cycles Using Cyclin-Dependent-Kinase Inhibitors: A New Therapeutic Approach for Pancreatic Cancer.
2022
Research grants (ARC, NHMRC, MRFF)
Targeting Dysregulated Transcription in Cancer Through Cyclin-Dependent-Kinase 11
RECENT SCHOLARLY WORKS
2024
Journal article
Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling
DOI: 10.1111/febs.171962022
Journal article
Development of an adenosquamous carcinoma histopathology - selective lung metastasis model
DOI: 10.1242/bio.0596232022
Journal article
Targeting transcription cycles in cancer
DOI: 10.1038/s41568-021-00411-82021
Journal article
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
DOI: 10.1016/j.cell.2021.04.0222021
Journal article
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
DOI: 10.1016/j.molcel.2021.04.0152021
Journal article
Serine biosynthesis is a metabolic vulnerability in flt3-itd–driven acute myeloid leukemia
DOI: 10.1158/2159-8290.CD-20-0738
RECENT PROJECTS
2018
Research grants (other domestic)
Targeting Dysregulated Gene Expression in Haematological Cancers With Cdk9 Inhibitors